Skip to content
healthcare.dev
Get a free key

XELJANZ XR

NDC 0069-0502, tofacitinib, tablet, film coated, extended release, from Pfizer Laboratories Div Pfizer Inc.

Product NDC
0069-0502
Status
Listed
Labeler
Pfizer Laboratories Div Pfizer Inc
Dosage form
TABLET, FILM COATED, EXTENDED RELEASE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA208246
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0069-0502 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • TOFACITINIB CITRATE22 mg/1

Pharmacologic classes

Janus Kinase Inhibitor [EPC]; Janus Kinase Inhibitors [MoA]

Package NDCNDC-11Package
0069-0502-300006905023030 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (0069-0502-30)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/cf74ba2f-afc5-4baa-8594-979c889a5831

Use it

Look up 0069-0502 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0069-0502 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0069-0502. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.